首页> 外文期刊>Journal of refractive surgery >Nomogram adjustment of laser in situ keratomileusis for myopia and myopic astigmatism with the Alcon LADARVision system.
【24h】

Nomogram adjustment of laser in situ keratomileusis for myopia and myopic astigmatism with the Alcon LADARVision system.

机译:使用Alcon LADARVision系统对近视和近视散光进行激光原位角膜磨镶术的射线摄影术调整。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the visual and refractive results of conventional (non-wavefront) laser in situ keratomileusis (LASIK) for treatment of myopia and myopic astigmatism using the Alcon LADARVision 4000 excimer laser system and nomogram adjustment techniques. METHODS: A retrospective analysis of 499 eyes that had LASIK for myopia and myopic astigmatism was performed. Preoperative manifest spherical equivalent refraction ranged from -0.43 to -6.00 D and preoperative astigmatism ranged from 0 to -4.75 D. Patients were evaluated during 3 months following surgery. RESULTS: One month after surgery, 72% of eyes examined (298/415 eyes) had uncorrected visual acuity (UCVA) of 20/20 or better. Three months after surgery, 83% of eyes examined (216/261 eyes) had UCVA of 20/20 or better. One and three months after surgery, 82% and 83% of eyes, respectively, were within +/-0.50 D of attempted correction; 97% of eyes were within +/-1.00 D at both 1 and 3 months. No eye lost more than 1 line of best spectacle-corrected visual acuity (BSCVA) at 3 months after surgery. At the 3-month examination, 83% of eyes had UCVA better than or equal to preoperative BSCVA. CONCLUSIONS: Conventional LASIK to correct myopia and myopic astigmatism was safe and effective using the Alcon LADARVision 4000 excimer laser system. Outcomes were substantially improved throughout development of an accurate nomogram, derived from continually updated regression analysis of previous refractive results.
机译:目的:使用Alcon LADARVision 4000准分子激光系统和列线图调整技术,评估常规(非波前)原位角膜磨镶术(LASIK)用于治疗近视和近视散光的视觉和屈光结果。方法:对499例LASIK手术的近视和近视散光进行回顾性分析。术前的等效球镜屈光度范围为-0.43至-6.00 D,术前散光的范围为0至-4.75D。在术后3个月内对患者进行了评估。结果:手术后一个月,接受检查的72%的眼睛(298/415眼)的未矫正视力(UCVA)为20/20或更高。手术后三个月,接受检查的83%的眼睛(216/261眼)的UCVA为20/20或更好。术后1个月和3个月,分别有82%和83%的眼睛位于尝试矫正的+/- 0.50 D之内。在1个月和3个月内,有97%的眼睛在+/- 1.00 D以内。术后3个月,没有眼睛损失超过1线的最佳眼镜矫正视力(BSCVA)。在3个月的检查中,有83%的眼睛的UCVA优于或等于术前BSCVA。结论:使用Alcon LADARVision 4000准分子激光系统矫正近视和近视散光的常规LASIK是安全有效的。从不断更新对先前屈光结果的回归分析得出的结果,在开发精确列线图的过程中,结果得到了显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号